Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV chlorpromazine versus IV prochlorperazine for acute migraine in the emergency department
ACTRN12618000138280Phase 4Terminated
- Sponsor
- Sarah Hodgson
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine comparing Chlorpromazine arm with Prochlorperazine arm (2 arms). Primary endpoint: Change in headache severity at 60 minutes. Started Apr 2018; status: terminated.
02
Drugs
Aminazinprochlorperazine
03
Conditions
migraine
Beyond the preview
Go deeper on ACTRN12618000138280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000138280.